Cyber-Monday-Deal: Bis zu 60% Rabatt auf InvestingProJETZT ZUGREIFEN

DGAP-News: Analogic Highlights Groundbreaking Quantum Technology at AUA Annual Meeting (deutsch)

Veröffentlicht am 17.05.2012, 19:45
Analogic Highlights Groundbreaking Quantum Technology at AUA Annual Meeting

Analogic Corporation

17.05.2012 19:45

---------------------------------------------------------------------------

New BK Medical Ultrasound Systems With Quantum Technology Offer Exceptional

Image Quality

PEABODY, Mass., 2012-05-17 19:45 CEST (GLOBE NEWSWIRE) --

Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and

aviation security technology, today announced that it will demonstrate its

suite of new BK Medical branded ultrasound systems--the Flex Focus(tm) 500, Flex

Focus 800, and Pro Focus(tm) UltraView 800 with the groundbreaking Quantum(tm)

Technology--at the American Urological Association Annual Meeting, May 19-23, in

Atlanta. Analogic's BK Medical branded systems with Quantum Technology offer

new features and solutions that provide clinicians a faster and easier way to

maximize ultrasound performance, specifically in urology and renal imaging.

Quantum Technology offers image quality advancements including improved

contrast resolution, as well as new grayscale maps and new image pre-sets,

making it easier and quicker to obtain the highest quality images. In addition,

the new technology includes a unique Vector Flow Imaging (VFI) mode*, allowing

angle independent visualization of blood flow, and an advanced color Doppler

mode, enabling superb spatial resolution. Key benefits also include advanced

harmonic imaging when imaging all patient types, even the extremely

difficult-to-image patient.

'The BK Medical ultrasound solution provides excellent 2D imaging, enabling

clinicians to visualize kidney anatomy out to the pyramids and capsule with

increased color Doppler resolution out to the renal cortex,' said Lars Shaw,

vice president of global marketing at Analogic. 'In addition, the vector flow

imaging mode allows for angle independent visualization of blood flow out to

the accurate arteries, leading to a more thorough patient assessment.'

Analogic's new ultrasound systems complement BK Medical's extensive product

portfolio. The Flex Focus 800 and UltraView 800 are premium performance, highly

efficient new systems that incorporate Quantum Technology. Compatible with all

of the BK Medical transducers, the fully featured systems are ideally suited

for surgery, including robotic-assisted surgery, high-end urology, and general

imaging.

The UltraView 800 system also has contrast imaging capabilities**. The Flex

Focus 500 is the mid-range system in the BK Medical product family

incorporating Quantum Technology. This portable system is powerful and well

suited for a busy practice utilizing ultrasound for urology and general imaging

needs. All of the new ultrasound systems have the VFI* as an option.

'Using the BK Medical ART system for robotic-assisted surgery allows us to

tackle more difficult, complex lesions that we would not have considered for a

minimally invasive approach in the past,' said Michael Stifelman, M.D.,

director, Robotic Surgery, NYU Langone Medical Center, New York City. 'This

technology raises image quality, color Doppler sensitivity, and ease of use to

a new level for our robotic-assisted surgery practice.'

Analogic's full BK Medical product portfolio includes the Flex Focus 200, 200

Surgery, 400, 400 Anesthesia, and the Pro Focus UltraView.

To see a live demonstration of the three new ultrasound systems with Quantum

Technology, please visit Analogic's BK Medical Systems booth #1731 during the

AUA Annual Meeting.

About Analogic and the BK Medical brand

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology

solutions to advance the practice of medicine and save lives. Analogic's

ultrasound group designs and manufactures ultrasound systems and specialized

transducers that are sold directly to medical practitioners under the BK

Medical brand. For over 30 years, our market-leading BK Medical branded

ultrasound solutions have been used to improve the practice of medicine in

procedure-driven markets such as urology, surgery and anesthesia. BK Medical's

products, including our award-winning Flex Focus family of systems and unique

transducer designs, offer advanced imaging capabilities that enable real-time

image guidance in an easy-to-use, portable platform. Our Analogic ultrasound

group has operations in Massachusetts, Pennsylvania, Colorado, Denmark, and

Shanghai.

For more information on our BK Medical ultrasound products visit www.bkmed.com.

For more information on Analogic, visit www.analogic.com.

* Flex Focus; VFI is not cleared by FDA and licensed by Health Canada. Pro

Focus; VFI is not licensed by Health Canada

** Contrast imaging capabilities are FDA cleared for cardiac applications only.

Analogic is a registered trademark of Analogic Corporation. The globe logo is a

trademark of Analogic Corporation.

CONTACT: Media Contact:

Amy Cook

(925) 552-7893

amycook@amcpublicrelations.com



Investor Contact:

Mark Namaroff

Director of Investor Relations

(978) 326-4058

investorrelations@analogic.com

News Source: NASDAQ OMX

17.05.2012 Dissemination of a Corporate News, transmitted by DGAP -

a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------



Language: English

Company: Analogic Corporation





United States

Phone:

Fax:

E-mail:

Internet:

ISIN: US0326572072

WKN:



End of Announcement DGAP News-Service



---------------------------------------------------------------------------

Aktuelle Kommentare

Installieren Sie unsere App
Risikohinweis: Beim Handel mit Finanzinstrumenten und/oder Kryptowährungen bestehen erhebliche Risiken, die zum vollständigen oder teilweisen Verlust Ihres investierten Kapitals führen können. Die Kurse von Kryptowährungen unterliegen extremen Schwankungen und können durch externe Einflüsse wie finanzielle, regulatorische oder politische Ereignisse beeinflusst werden. Durch den Einsatz von Margin-Trading wird das finanzielle Risiko erhöht.
Vor Beginn des Handels mit Finanzinstrumenten und/oder Kryptowährungen ist es wichtig, die damit verbundenen Risiken vollständig zu verstehen. Es wird empfohlen, sich gegebenenfalls von einer unabhängigen und sachkundigen Person oder Institution beraten zu lassen.
Fusion Media weist darauf hin, dass die auf dieser Website bereitgestellten Kurse und Daten möglicherweise nicht in Echtzeit oder vollständig genau sind. Diese Informationen werden nicht unbedingt von Börsen, sondern von Market Makern zur Verfügung gestellt, was bedeutet, dass sie indikativ und nicht für Handelszwecke geeignet sein können. Fusion Media und andere Datenanbieter übernehmen daher keine Verantwortung für Handelsverluste, die durch die Verwendung dieser Daten entstehen können.
Die Nutzung, Speicherung, Vervielfältigung, Anzeige, Änderung, Übertragung oder Verbreitung der auf dieser Website enthaltenen Daten ohne vorherige schriftliche Zustimmung von Fusion Media und/oder des Datenproviders ist untersagt. Alle Rechte am geistigen Eigentum liegen bei den Anbietern und/oder der Börse, die die Daten auf dieser Website bereitstellen.
Fusion Media kann von Werbetreibenden auf der Website aufgrund Ihrer Interaktion mit Anzeigen oder Werbetreibenden vergütet werden.
Im Falle von Auslegungsunterschieden zwischen der englischen und der deutschen Version dieser Vereinbarung ist die englische Version maßgeblich.
© 2007-2024 - Fusion Media Limited. Alle Rechte vorbehalten.